Cyto-Zyme
Natural health product licensed in Canada
- Licence holder
- Cyto-Matrix Inc.
- NPN or DIN-HM
- 80054630
- Status
- Active licence
- Licence date
- 7 October 2014
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Trigonella foenum-graecum L.: L'étiquetage doit comporter un avertissement déconseillant l'emploi aux femmes enceintes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 1,4-alpha-D-Glucane glucohydrolase Source : Aspergillus niger - En entier | 11.1 mg | Not calculated |
| 1,4-alpha-D-Glucane glucohydrolase Source : Aspergillus niger - En entier | 5 Unité de glucoamylase du FCC | Not calculated |
| Zingiber officinale Source : Zingiber officinale - Rhizome | 60 mg | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Aspergillus flavus var. oryzae - En entier | 25 mg | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Aspergillus flavus var. oryzae - En entier | 2,500 FCC DU | Not calculated |
| Protéase Source : Aspergillus flavus var. oryzae - En entier | 8 mg | Not calculated |
| Protéase Source : Aspergillus flavus var. oryzae - En entier | 2,000 FCC HUT | Not calculated |
| Trigonella foenum-graecum Source : Trigonella foenum-graecum - Graine | 50 mg | Not calculated |
| Protéase Source : Aspergillus flavus var. oryzae - En entier | 15,000 FCC HUT | Not calculated |
| Protéase Source : Aspergillus flavus var. oryzae - En entier | 30 mg | Not calculated |
| bêta-fructofuranosidase Source : Saccharomyces cerevisiae - en entier | 20 mg | Not calculated |
| bêta-fructofuranosidase Source : Saccharomyces cerevisiae - en entier | 200 FCC SU | Not calculated |
| Protéase Source : Aspergillus flavus var. oryzae - En entier | 16 mg | Not calculated |
| Protéase Source : Aspergillus flavus var. oryzae - En entier | 8,000 FCC HUT | Not calculated |
| Protéase Source : Aspergillus niger - En entier | 10 FCC SAPU | Not calculated |
| Protéase Source : Aspergillus niger - En entier | 9.3 mg | Not calculated |
| alpha-D-Galactoside galactohydrolase Source : Aspergillus niger - En entier | 125 FCC GalU | Not calculated |
| alpha-D-Galactoside galactohydrolase Source : Aspergillus niger - En entier | 8.3 mg | Not calculated |
| Triacylglycérol lipase Source : Rhizopus oryzae - En entier | 150 FCC LU | Not calculated |
| Triacylglycérol lipase Source : Rhizopus oryzae - En entier | 7.5 mg | Not calculated |
| Diastase du malt Source : Aspergillus flavus var. oryzae - En entier | 7.4 mg | Not calculated |
| Diastase du malt Source : Aspergillus flavus var. oryzae - En entier | 200 FCC DP | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Trichoderma longibrachiatum - En entier | 300 FCC CU | Not calculated |
| 4-(1,3;1,4)-bêta-D-glucane 4-glucanohydrolase Source : Trichoderma longibrachiatum - En entier | 3.8 mg | Not calculated |
| bêta-galactosidase Source : Aspergillus flavus var. oryzae - En entier | 100 FCC ALU | Not calculated |
| bêta-galactosidase Source : Aspergillus flavus var. oryzae - En entier | 1 mg | Not calculated |
Non-medicinal ingredients
NA, Son de riz, Hypromellose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 1 Capsule ; maximum: 2 Capsule | 3 Tous les jours |
Uses authorised in Canada
Digestive aid. Digestive enzyme. Helps digest proteins. Helps reduce gas production/flatulence following a meal rich in fermentable carbohydrates (such as vegetables, pulses/legumes/beans and whole grains). Helps prevent gastrointestinal intolerance of oligosaccharides/fermentable carbohydrates.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Hypersensitivity/allergy has been known to occur; in which case, discontinue use. Headaches, heartburn, bloating and hypersensitivity (e.g. allergy) have been known to occur; in which case, discontinue use.
- Précautions et mises en garde
If you are pregnant or breastfeeding, consult a health care practitioner prior to use. If you have a gastrointestinal lesion/ulcer, are taking an anticoagulant/ blood thinner or an anti-inflammatory, or are having surgery, consult a health care practitioner prior to use. If you have diabetes, consult a health care practitioner prior to use. If symptoms persist or worsen, consult a health care practitioner.
Source
Official Health Canada record, licence 80054630
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.